Table 5.
Summary of outcomes from standardized cognitive assessment scales.
| Study | Within groups | Between groups | Follow-up |
|---|---|---|---|
| DEMENTIA | |||
| Surmeli et al. (2016) |
NF: ↑ MMSE (19.00%) |
N/A | N/A |
| Luijmes et al. (2016) |
NF: ↑ CAMCOG (2.00%) |
N/A | N/A |
| Hohenfeld et al. (2017) |
NF: ↓ MoCA (1.00%) CG1: ↑ MoCA (3.97%) CG2: ↑ MoCA (0.83%) |
NR | N/A |
| Hohenfeld et al. (2020) | NR |
CG>NF: ↑ MoCA |
N/A |
| MCI | |||
| Mendoza Laiz et al. (2018) | NR | NR | N/A |
| Jang et al. (2019) |
NF: ↑ MoCA-K (20.67%) |
N/A | N/A |
| Jirayucharoensak et al. (2019) | NR | NR | N/A |
| Lavy et al. (2019) | NR | N/A | NR |
| Li et al. (2020) | NR | N/A | N/A |
| Marlats et al. (2020) |
NF:
↑ MMSE (1.67%) ↑ MoCA (6.33%) |
N/A | Regression of MoCA improvement |
CAMCOG, Cambridge Cognitive Examination; CG, Control Group; MMSE, Mini Mental Status Examination; MoCA, Montreal Cognitive Assessment; MoCA-K, Montreal Cognitive Assessment-Korean version; N/A, Not Apply; NF, Neurofeedback; NR, Not Reported; ↑, increased; ↓, decreased.